Letters Section Editor: Jody W. Zylke, MD, Senior Editor.
Author Affiliations: Karolinska Institutet, Stockholm, Sweden (firstname.lastname@example.org).
To the Editor: Mr Svanström and colleagues1 reported that losartan was not associated with increased all-cause mortality compared with candesartan in patients with a diagnosis of heart failure based on International Classification of Disease(ICD) codes. This contrasts with previous data from our group2 and others.
Lund LH, Benson L. Losartan vs Candesartan for Heart Failure. JAMA. 2012;308(4):336–337. doi:10.1001/jama.2012.7642
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: